Small biotech niche ACD is a boutique biotechnology research provider with a focus on cell-based assay systems and targeted capabilities in kinases, GPCRs, ion channels, and transcription factors, presenting an opportunity to upsell specialized contract research services to mid-size pharma and niche biotechs.

Contract research upside Current revenue model includes contract research services; potential sales angle includes expanding scope of in vitro assays, gene editing in stem cells, and custom assay development for oncology, immunology, and neurobiology programs.

Global client reach Position ACdynamics as a flexible partner for international clients seeking custom cell-based assays, enabling cross-border collaborations, CRO partnerships, and rapid pilot projects to de-risk larger engagements.

Partnership-ready scale With a small team footprint, emphasize lean, high-quality, fast-turnaround engagements and consider white-label or co-development models to attract larger clients while maintaining agility.

Competitive positioning Highlight deep domain expertise in kinases, GPCRs, ion channels, and transcription factors as differentiators against larger CROs; target mid-tier biotechs and research institutes seeking specialized assay development and bespoke cell-based platforms.